SPAC IPO Terms Tracker: More of the Same for September
by sam.beattie on 2022-09-17 at 12:02pm

Terms Tracker for the Week Ending September 16th, 2022

Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings.

For the week ending September 16th, there were just two new S-1 registration statements, up from the zero seen last week, and zero IPOs, one less than the week prior. This week consisted of the first two new S-1s of the month and as we are about halfway to October, we may see similar numbers as last August. The total number of SPACs in registration remained unchanged at 116 while the total number of SPACs searching for targets took a deeper drop to 557 from 565 the week prior.

Breaking it down, the filed column gained two new S-1s and lost two due to registration withdrawals (RWs), while the searching column decreased due to two liquidations, and six deal announcements. It was another relatively light week for SPACs, however, we are still noticing a mild increase in amendments to S-1s with no changes to terms (in regard to the Terms Diffusion Tracker) which may be foreshadowing an increase in IPOs for the weeks ahead.

[Read here for a refresher on our methodology]

Terms Tracker Data

The Terms Diffusion Index dropped to 49.66 from 49.92 last week. The retraction was a result of four negative changes, three more than the week prior. TenX Keane Acquisition (TENK) shortened their time horizon from 12 to 9 months and increased their rights coverage from 1 for 1/10 to 1 for 2/10 – a more unusual term for rights coverage. Cetus Capital Acquisition Corp. (CETU) added rights coverage of 1 for 1/10 and overfunded from 102.0% to 102.5%.

So far, September has proven to be relatively moderate in terms of changes and volume for the Diffusion Index however we have started to notice a consistency in deal liquidations, which has become a contributor to the fluxing index. In terms of the overall SPAC market, it’s likely we will continue to see the long-standing trend of the year continue.

  • The Terms Diffusion Index oscillates around 50.0, assigning a 1.0 value to all positive changes, a 0.5 value to “no changes”, and a 0.0 value to negative changes. Therefore, readings above 50.0 would indicate SPAC terms were loosening on the week, while a reading below 50.0 signals tightening.

IPO Performances from Last Week

There were no IPOs this week leaving the monthly total of one IPO unchanged. As the weather begins to cool and Fall sets in, the number of pricings in SPACland may experience a similar movement, however, considering the already low level of IPOs seen this year, it may remain consistent.

Note: Based on the unit’s (or share’s) day-1 VWAP.

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved